These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6337426)

  • 41. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 42. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
    Brechter C; Bäcklund H; Krook H; Müller R; Nitelius E; Olsson JE; Olsson O; Thornberg A
    Lakartidningen; 1980 Dec; 77(52):4947-56. PubMed ID: 7010029
    [No Abstract]   [Full Text] [Related]  

  • 43. The role of the neurologist in the decline of stroke.
    Whisnant JP
    Ann Neurol; 1983 Jul; 14(1):1-7. PubMed ID: 6614869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue-type plasminogen activator should not be used in acute ischemic stroke.
    Riggs JE
    Arch Neurol; 1996 Dec; 53(12):1306-8. PubMed ID: 8970462
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of stroke: medical or surgical?
    Vroom FQ
    Geriatrics; 1974 Mar; 29(3):123-6 passim. PubMed ID: 4813852
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term prognosis of infratentorial transient ischemic attacks and minor strokes.
    Hornig CR; Lammers C; Büttner T; Hoffmann O; Dorndorf W
    Stroke; 1992 Feb; 23(2):199-204. PubMed ID: 1561648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability?
    Chaturvedi S; Ansell J; Recht L
    Stroke; 1994 Jun; 25(6):1215-8. PubMed ID: 8202983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
    Hills NK; Johnston SC
    Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Placebo-controlled, double-blind clinical trials can impede medical progress.
    Ritter JM
    Lancet; 1980 May; 1(8178):1126-7. PubMed ID: 6103452
    [No Abstract]   [Full Text] [Related]  

  • 50. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
    Franzini C; Ferrante P
    Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
    [No Abstract]   [Full Text] [Related]  

  • 51. [Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
    Inzitari D; Fratiglioni L; Baldereschi M; Candelise L; Anzalone N; Bonatti ML; Prencipe M; Gandolfo C; Mamoli A; Rasura M
    Epidemiol Prev; 1990 Jun; 12(43):6-11. PubMed ID: 2149110
    [No Abstract]   [Full Text] [Related]  

  • 52. [Future treatment of stroke. Brain damage in stroke can be reduced by drugs].
    Siesjö BK
    Lakartidningen; 1993 Sep; 90(36):2958, 2962-4. PubMed ID: 8366724
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial: rationale and design.
    Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Held P; Jonasson J; Minematsu K; Molina CA; Wong LK
    Int J Stroke; 2015 Dec; 10(8):1304-8. PubMed ID: 26311628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspirin wars: the optimal dose of aspirin prevent stroke.
    Hart RG; Harrison MJ
    Stroke; 1996 Apr; 27(4):585-7. PubMed ID: 8614911
    [No Abstract]   [Full Text] [Related]  

  • 55. The European Stroke Prevention Study (ESPS): results by arterial distribution.
    Sivenius J; Riekkinen PJ; Smets P; Laakso M; Lowenthal A
    Ann Neurol; 1991 Jun; 29(6):596-600. PubMed ID: 1892362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM
    Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of transient ischemic attacks.
    Dobkin BH
    Hosp Pract (Off Ed); 1987 Mar; 22(3):113-7, 120, 123-4 passim. PubMed ID: 3102509
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prognosis and drug therapy in ischemic cerebrovascular disorders].
    Waltimo O
    Duodecim; 1973; 89(5):380-5. PubMed ID: 4727002
    [No Abstract]   [Full Text] [Related]  

  • 59. Proceedings: The effect of a platelet inhibiting drug (sulfinpyrazone) in the therapy of patients with transient ischemic attacks (Tia's) and minor strokes.
    Robertson JT; Dugdale M; Salky N; Robinson H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):598. PubMed ID: 1105880
    [No Abstract]   [Full Text] [Related]  

  • 60. Transient ischemic attacks and ischemic stroke: indications for anticoagulation.
    Miller VT
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI29-30. PubMed ID: 2191813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.